Counsyl

Counsyl

DNA screening and genetic counseling for diseases that can impact men, women & their children. Counsyl is the US leader in ECS. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$2.2m

Early VC
N/A

$11.1m

Early VC
N/A

$7.5m

Series A

$54.0m

Growth Equity VC

$7.5m

Series C

$28.0m

Series D

$80.0m

-

$375m

Acquisition
Total FundingAUD294m

Recent News about Counsyl

Edit
More about Counsylinfo icon
Edit

Myriad Women's Health, formerly known as Counsyl, specializes in genetic testing services aimed at reproductive health. The company operates in the healthcare sector, focusing on providing genetic screening and counseling services to individuals planning a pregnancy or concerned about their reproductive health. Myriad Women's Health serves a diverse range of clients, including patients, healthcare providers, and telehealth platforms. The business model revolves around offering genetic tests that can be ordered online or through healthcare providers, followed by detailed counseling sessions to interpret the results. Revenue is generated through the sale of these genetic tests and associated counseling services. The company leverages telehealth to make genetic testing more accessible, especially in the post-COVID-19 world, where remote healthcare solutions are increasingly in demand.

Keywords: genetic testing, reproductive health, telehealth, personalized care, healthcare, genetic counseling, telemedicine, patient education, remote solutions, reproductive risk.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.